SCHEMBL5032704

SCHEMBL5032704

Nc1cccc(S(=O)(=O)N2CCCC2CO)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOX P28300 1/20 0.61
HTR7 P34969 8/20 0.50
HTR1B P28222 4/20 0.50
DRD3 P35462 4/20 0.50
HTR1A P08908 3/20 0.50
DRD2 P14416 3/20 0.50
HTR1D P28221 3/20 0.50
CYP2D6 P10635 2/20 0.50
HTR5A P47898 2/20 0.50
HTR6 P50406 2/20 0.50
PLAU P00749 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP1A2 P05177 1/20 0.50
HTR2B P41595 1/20 0.50
HTR4 Q13639 1/20 0.50
TMEM97 Q5BJF2 2/20 0.49
ADRA2A P08913 1/20 0.49
ADRA2B P18089 1/20 0.49
ADRA2C P18825 1/20 0.49
OPRM1 P35372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5032639 1.00 LOX (0.61) LOXHTR7HTR1BDRD3HTR1A
SCHEMBL1684351 0.87 LOX (0.51) LOXPLAUBRD4BRD2PIK3CD
SCHEMBL1684352 0.87 LOX (0.51) LOXPLAUBRD4BRD2PIK3CD
SCHEMBL5808140 0.85 HTR7 (0.52) LOXHTR7HTR1BDRD3HTR1A
SCHEMBL19259832 0.84 LOX (0.58) LOXHTR7HTR1BDRD3HTR1A
SCHEMBL19259831 0.84 LOX (0.58) LOXHTR7HTR1BDRD3HTR1A
SCHEMBL19259718 0.84 LOX (0.58) LOXHTR7HTR1BDRD3HTR1A
SCHEMBL19259717 0.84 LOX (0.58) LOXHTR7HTR1BDRD3HTR1A
SCHEMBL5032633 0.84 LOX (0.58) LOXHTR7HTR1BDRD3HTR1A
SCHEMBL15256572 0.83 BRD4 (0.57) LOXHTR7HTR6PLAUBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378417-B2 Pyrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US disclosed
EP-1761541-B1 PYRRAZOLO-PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-09 EP disclosed
EP-1761541-A1 PYRRAZOLO-PYRIMIDINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2007-03-14 EP disclosed
WO-2005123738-A1 PYRRAZOLO-PYRIMIDINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2005-12-29 WO disclosed
US-20050282827-A1 Pyrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282827-A1 Pyrazolo-pyrimidine derivatives P2RX3, P2RX1, P2RX5 LOX 4212/4885HTR7 1053/4885HTR1B 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.